Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFidelity European Values Regulatory News (FEV)

Share Price Information for Fidelity European Values (FEV)

Share Price is delayed by 15 minutes
Get Live Data
432.50    -0.50 (-0.12%)
Bid:
431.50
Ask:
432.50
Spread: 1.00 (0.232%)
Market Cap: £2.15b
FEV Live PriceLast checked at - London Stock Exchange

Intraday Fidelity European Values Share Chart

Hardman & Co Research - A commendable performance

20 Feb 2023 16:10

RNS Number : 4865Q
Fidelity European Trust PLC
20 February 2023
 

Hardman & Co Research on Fidelity European Trust Plc (FEV):

A commendable performance in a difficult year

In our most recent note, Continued resilience in difficult markets, published on 23 November 2022, we analysed how FEV had performed YTD, and highlighted a few of the macro issues that dominated the European equity markets during 2022. In this note, we look back at the 2022 performance, putting it in its longer-term historical context and comparing it with FEV's peer group performance in 2022. We touch briefly on the outlook for 2023, but we also remind investors that FEV's long-term track record is driven by bottom-up stock selection.  

 

Please click on the link below for the full report:

https://hardmanandco.com/research/corporate-research/a-commendable-performance-in-a-difficult-year/

If you are interested in meeting the company, you can register your interest by clicking on the above link.

 

To contact us:

Hardman & Co1 Frederick's Place

London

EC2R 8AE

www.hardmanandco.com

Follow us on Twitter @HardmanandCo

Contact:

Riccardo Bindi+44 (0)203 693 7075

 

rb@hardmanandco.com

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259. Attention is drawn to the important disclaimers at the end of the report.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABLGDDBGDDGXG
Date   Source Headline
30th Mar 20267:53 amRNSNet Asset Value(s)
27th Mar 20267:59 amRNSNet Asset Value(s)
26th Mar 20267:37 amRNSNet Asset Value(s)
25th Mar 20264:41 pmPRNTransaction in Own Shares
25th Mar 20267:37 amRNSNet Asset Value(s)
24th Mar 20265:00 pmPRNTransaction in Own Shares
24th Mar 202612:09 pmPRNDirector/PDMR Shareholding
24th Mar 20267:46 amRNSNet Asset Value(s)
23rd Mar 20267:49 amRNSNet Asset Value(s)
20th Mar 20267:55 amRNSNet Asset Value(s)
19th Mar 20267:56 amRNSNet Asset Value(s)
18th Mar 20267:49 amRNSNet Asset Value(s)
18th Mar 20267:00 amPRNAnnual Financial Report
17th Mar 20267:49 amRNSNet Asset Value(s)
16th Mar 20267:44 amRNSNet Asset Value(s)
13th Mar 20267:42 amRNSNet Asset Value(s)
13th Mar 20267:00 amRNS-RKepler Trust Intelligence: New Research
13th Mar 20267:00 amRNS-RKepler Trust Intelligence: New Research
12th Mar 20267:35 amRNSNet Asset Value(s)
10th Mar 20264:59 pmRNSTransaction in Own Shares
10th Mar 20264:59 pmPRNTransaction in Own Shares
10th Mar 20267:56 amRNSNet Asset Value(s)
9th Mar 20267:38 amRNSNet Asset Value(s)
6th Mar 20265:03 pmPRNTransaction in Own Shares
6th Mar 20267:50 amRNSNet Asset Value(s)
5th Mar 20265:00 pmPRNTransaction in Own Shares
5th Mar 20268:00 amRNSNet Asset Value(s)
4th Mar 20265:01 pmPRNTransaction in Own Shares
4th Mar 20268:03 amRNSNet Asset Value(s)
3rd Mar 202610:46 amPRNMonthly Factsheet
3rd Mar 20267:46 amRNSNet Asset Value(s)
2nd Mar 20263:59 pmPRNTotal Voting Rights
2nd Mar 20267:48 amRNSNet Asset Value(s)
27th Feb 20267:59 amRNSNet Asset Value(s)
26th Feb 20267:45 amRNSNet Asset Value(s)
25th Feb 20267:47 amRNSNet Asset Value(s)
24th Feb 20267:36 amRNSNet Asset Value(s)
23rd Feb 20267:39 amRNSNet Asset Value(s)
20th Feb 20267:53 amRNSNet Asset Value(s)
19th Feb 20267:55 amRNSNet Asset Value(s)
18th Feb 20268:00 amRNSNet Asset Value(s)
17th Feb 20267:48 amRNSNet Asset Value(s)
16th Feb 20267:51 amRNSNet Asset Value(s)
13th Feb 20267:51 amRNSNet Asset Value(s)
12th Feb 20267:43 amRNSNet Asset Value(s)
11th Feb 20267:53 amRNSNet Asset Value(s)
10th Feb 20267:51 amRNSNet Asset Value(s)
10th Feb 20267:00 amPRNCompliance with Market Abuse Regulations
9th Feb 20267:35 amRNSNet Asset Value(s)
6th Feb 20267:50 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.